Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Nthabiseng Bapela: Interpreting INR in Patients on Warfarin – A Practical Clinical Framework
Nthabiseng Bapela/LinkedIn
Jul 6, 2026, 19:22

Nthabiseng Bapela: Interpreting INR in Patients on Warfarin – A Practical Clinical Framework

Nthabiseng Bapela, Healthcare Intelligence System Specialist at MerithRX, shared a post on LinkedIn:

“Interpreting INR in patients on warfarin: a practical clinical framework

The International Normalized Ratio (INR) is central to monitoring warfarin therapy, but it should never be interpreted in isolation. An INR result only becomes meaningful when considered alongside the patient’s indication for anticoagulation, target range, bleeding risk, and current clinical context.

A structured approach to INR interpretation

1. Confirm the indication for warfarin

Start by identifying why the patient is anticoagulated. Common indications include:

  • Atrial fibrillation
  • DVT and PE
  • Mechanical prosthetic heart valves

This matters because the target INR depends on the indication and, in valve patients, the type of valve.

2. Compare the result with the patient’s target INR

In broad terms:

  • INR below target indicates subtherapeutic anticoagulation, with an increased thromboembolic risk
  • INR within target indicates therapeutic anticoagulation
  • INR above target indicates supratherapeutic anticoagulation, with an increased bleeding risk

3. Interpret the INR in clinical context

An abnormal INR should prompt review of factors that commonly affect warfarin control:

  • Missed or extra doses
  • Drug interactions (e.g. antibiotics, azole antifungals, amiodarone, NSAIDs, antiplatelets, herbal products)
  • Dietary vitamin K changes
  • Alcohol intake
  • Acute illness, diarrhoea, vomiting, reduced oral intake, or liver dysfunction
  • Trend in previous INR results

4. Assess the patient, not just the laboratory value

Always consider whether there is evidence of:

  • Bleeding: melaena, haematuria, epistaxis, bruising, heavy menstrual bleeding, haematemesis, or unexplained anaemia
  • Thromboembolism if the INR is low: stroke symptoms, chest pain, dyspnoea, or limb swelling depending on the indication

Why this matters

Warfarin remains a high-risk medicine because both under-anticoagulation and over-anticoagulation can cause harm. A low INR may leave the patient inadequately protected from stroke, recurrent VTE, or valve thrombosis, while a high INR increases the risk of major bleeding.

Pharmacist practice point

INR is not simply a number to classify as low or high. It is a marker of anticoagulation intensity that must be interpreted in relation to the patient’s indication, target range, medicines, comorbidities, and clinical presentation.

For pharmacists, reviewing INR means asking not only ‘Is this result out of range?’ but also ‘Why is it out of range, and is the patient safe right now?'”

Nthabiseng Bapela

Stay updated with Hemostasis Today.

Anticoagulation Atrial Fibrillation Blood Cardiology DVT Health Hematology Hemostasis News Hemostasis Today INR International Normalized Ratio Medicine Nthabiseng Bapela PE thromboembolism Vitamin K Warfarin
NewsFeed